NOCDURNA ORAL LYOPHILISATE 25MCG
Product details
Registration number: SIN15461P
Classification: Prescription Only
Active ingredients: Desmopressin acetate 28mcg eqv to desmopressin
Strength: 25mcg
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: SUBLINGUAL
Registrant: FERRING PHARMACEUTICALS PRIVATE LIMITED
ATC code: H01BA02
HSA approval date: 3 April 2018
Manufacturer(s): Catalent UK Swindon Zydis Limited
Manufacturing country/countries: UNITED KINGDOM
What are the HSA registration number and classification for NOCDURNA ORAL LYOPHILISATE 25MCG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15461P
Classification: Prescription Only
What active ingredients and strength are recorded for NOCDURNA ORAL LYOPHILISATE 25MCG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Desmopressin acetate 28mcg eqv to desmopressin
Strength: 25mcg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for NOCDURNA ORAL LYOPHILISATE 25MCG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: SUBLINGUAL
Who is the recorded registrant for NOCDURNA ORAL LYOPHILISATE 25MCG?
According to the HSA dataset updated 7 August 2026:
Registrant: FERRING PHARMACEUTICALS PRIVATE LIMITED
Which manufacturers and countries are listed for NOCDURNA ORAL LYOPHILISATE 25MCG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Catalent UK Swindon Zydis Limited
Manufacturing country/countries: UNITED KINGDOM
Where can I look up NOCDURNA ORAL LYOPHILISATE 25MCG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15461P or the exact product name NOCDURNA ORAL LYOPHILISATE 25MCG. The general register link does not preselect this product.
What are the source dates for this NOCDURNA ORAL LYOPHILISATE 25MCG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this NOCDURNA ORAL LYOPHILISATE 25MCG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15461P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)